Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-10-23 02:53 | 2020-10-20 | EAR | N/A | MAKOWER JOSHUA | Director, 10% owner | Other | BUY | $18.00 | 311,111 | $5,599,998 | 6,520,017 | +5.0% |
| 2020-10-23 03:34 | 2020-10-20 | ARYB | N/A | PERCEPTIVE ADVISORS LLC | Director | Other | BUY | $10.02 | 157,295 | $1,576,835 | 157,295 | +100.0% |
| 2020-10-21 20:01 | 2020-10-19 | VTA | N/A | Saba Capital Management, L.P. | 10% owner | Other | BUY | $9.35 | 602,072 | $5,631,059 | 7,080,122 | +9.3% |
| 2020-10-21 20:12 | 2020-10-19 | EFT | Eaton Vance Floating-Rate Income Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $12.77 | 285,528 | $3,646,021 | 4,305,910 | +7.1% |
| 2020-10-22 03:55 | 2020-10-19 | TMTSU | N/A | SUBIN NEIL S | 10% owner | Other | BUY | $10.00 | 500,000 | $5,000,000 | 500,000 | +100.0% |
| 2020-10-21 02:59 | 2020-10-20 | TARS | Tarsus Pharmaceuticals, Inc. | Horowitz Limited Partnership VIII | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $16.00 | 184,375 | $2,950,000 | 66,172 | +100.0% |
| 2020-10-21 02:56 | 2020-10-20 | TARS | Tarsus Pharmaceuticals, Inc. | Tester Jason E. | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $16.00 | 171,875 | $2,750,000 | 1,920,933 | +9.8% |
| 2020-10-21 02:58 | 2020-10-20 | TARS | Tarsus Pharmaceuticals, Inc. | Vivo Capital IX, LLC | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $16.00 | 250,000 | $4,000,000 | 3,245,035 | +8.3% |
| 2020-10-20 23:58 | 2020-10-20 | ALGS | Aligos Therapeutics Inc. | Versant Venture Capital VI, L.P. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $15.00 | 200,000 | $3,000,000 | 862,444 | +30.2% |
| 2020-10-21 00:00 | 2020-10-20 | ALGS | Aligos Therapeutics Inc. | Woiwode Thomas | Director | Biological Products, (No Diagnostic Substances) | BUY | $15.00 | 200,000 | $3,000,000 | 862,444 | +30.2% |
| 2020-10-20 23:59 | 2020-10-20 | ALGS | Aligos Therapeutics Inc. | Vivo Capital VIII, LLC | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $15.00 | 550,000 | $8,250,000 | 430,372 | +100.0% |
| 2020-10-21 03:01 | 2020-10-20 | TARS | Tarsus Pharmaceuticals, Inc. | Frazier Life Sciences IX, L.P. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $16.00 | 312,500 | $5,000,000 | 1,917,157 | +19.5% |
| 2020-10-20 23:00 | 2020-10-16 | RADI | N/A | DKLDO IV Trading Subsidiary LP | 10% owner | Other | BUY | $8.00 | 500,000 | $4,000,000 | 6,852,901 | +7.9% |
| 2020-10-21 03:03 | 2020-10-16 | CDAK | N/A | GILLIS STEVEN | Director | Other | BUY | $15.00 | 235,000 | $3,525,000 | 2,503,903 | +10.4% |
| 2020-10-21 03:05 | 2020-10-16 | CDAK | N/A | Flagship Ventures Fund V General Partner LLC | 10% owner | Other | BUY | $15.00 | 165,000 | $2,475,000 | 1,143,177 | +16.9% |
| 2020-10-21 03:07 | 2020-10-16 | CDAK | N/A | ARCH Venture Fund VIII, L.P. | 10% owner | Other | BUY | $15.00 | 235,000 | $3,525,000 | 2,503,903 | +10.4% |
| 2020-10-21 01:07 | 2020-10-16 | SELB | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Director, 10% owner | Pharmaceutical Preparations | BUY | $2.30 | 1,887,696 | $4,336,226 | 10,836,256 | +21.1% |
| 2020-10-19 23:15 | 2020-10-19 | ARRY | Array Technologies Inc. | Forth John Bradford | Director | Miscellaneous Manufacturing Industries | BUY | $22.00 | 60,924 | $1,340,328 | 60,924 | +100.0% |
| 2020-10-19 23:15 | 2020-10-19 | ARRY | Array Technologies Inc. | Bolland Stuart M. | Officer - Chief Operations Officer | Miscellaneous Manufacturing Industries | BUY | $22.00 | 53,461 | $1,176,142 | 53,461 | +100.0% |
| 2020-10-19 23:15 | 2020-10-19 | ARRY | Array Technologies Inc. | Krantz Jeffrey P. | Officer - Chief Commercial Officer | Miscellaneous Manufacturing Industries | BUY | $22.00 | 71,281 | $1,568,182 | 71,281 | +100.0% |
| 2020-10-19 23:15 | 2020-10-19 | ARRY | Array Technologies Inc. | MacVane Charlotte A. | Officer - See Remarks | Miscellaneous Manufacturing Industries | BUY | $22.00 | 77,221 | $1,698,862 | 77,221 | +100.0% |
| 2020-10-20 00:54 | 2020-10-16 | PFLEX | PIMCO Flexible Credit Income Fund Class A-4 | MURATA ALFRED T | Other | Other | BUY | $8.69 | 118,411 | $1,028,992 | 120,831 | +4,893.0% |
| 2020-10-20 03:49 | 2020-08-14 | FSDC | Disc Medicine, Inc. | FS Development Holdings, LLC | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 441,500 | $4,415,000 | 441,500 | +100.0% |
| 2020-10-19 20:32 | 2020-10-16 | VTA | N/A | Saba Capital Management, L.P. | 10% owner | Other | BUY | $9.35 | 180,136 | $1,684,272 | 6,478,050 | +2.9% |
| 2020-10-19 23:15 | 2020-10-19 | ARRY | Array Technologies Inc. | Fusaro James MacMillan | Director, Officer - Chief Executive Officer | Miscellaneous Manufacturing Industries | BUY | $22.00 | 182,772 | $4,020,984 | 182,772 | +100.0% |
| 2020-10-19 23:56 | 2020-10-13 | RADI | N/A | DKLDO IV Trading Subsidiary LP | 10% owner | Other | BUY | $8.00 | 704,337 | $5,634,696 | 6,352,901 | +12.5% |
| 2020-10-17 01:15 | 2020-10-14 | EBC | Eastern Bankshares, Inc. | Heinemann Barbara Jane | Officer - Executive VP | Savings Institution, Federally Chartered | BUY | $10.00 | 102,000 | $1,020,000 | 42,000 | +100.0% |
| 2020-10-17 00:52 | 2020-10-14 | EBC | Eastern Bankshares, Inc. | Sullivan Daniel J | Officer - Chief Credit Officer | Savings Institution, Federally Chartered | BUY | $10.00 | 100,000 | $1,000,000 | 65,000 | +100.0% |
| 2020-10-17 00:48 | 2020-10-14 | EBC | Eastern Bankshares, Inc. | Miller Jan Allan | Officer - Chief Cml Banking Officer | Savings Institution, Federally Chartered | BUY | $10.00 | 100,000 | $1,000,000 | 100,000 | +100.0% |
| 2020-10-17 00:41 | 2020-10-14 | EBC | Eastern Bankshares, Inc. | Fitzgerald James Burke | Officer - Chief Financial Officer | Savings Institution, Federally Chartered | BUY | $10.00 | 150,000 | $1,500,000 | 17,769 | +100.0% |
| 2020-10-17 00:34 | 2020-10-14 | EBC | Eastern Bankshares, Inc. | Spiess Paul Davis | Director | Savings Institution, Federally Chartered | BUY | $10.00 | 100,000 | $1,000,000 | 50,000 | +100.0% |
| 2020-10-17 00:32 | 2020-10-14 | EBC | Eastern Bankshares, Inc. | Shell Greg Allen Sr. | Director | Savings Institution, Federally Chartered | BUY | $10.00 | 200,000 | $2,000,000 | 200,000 | +100.0% |
| 2020-10-17 00:30 | 2020-10-14 | EBC | Eastern Bankshares, Inc. | Markell Peter Kenneth | Director | Savings Institution, Federally Chartered | BUY | $10.00 | 100,000 | $1,000,000 | 100,000 | +100.0% |
| 2020-10-17 00:19 | 2020-10-14 | EBC | Eastern Bankshares, Inc. | Bane Richard Corey | Director | Savings Institution, Federally Chartered | BUY | $10.00 | 120,000 | $1,200,000 | 120,000 | +100.0% |
| 2020-10-17 00:14 | 2020-10-14 | EBC | Eastern Bankshares, Inc. | Holbrook Richard Edward | Director | Savings Institution, Federally Chartered | BUY | $10.00 | 196,500 | $1,965,000 | 196,500 | +100.0% |
| 2020-10-17 00:12 | 2020-10-14 | EBC | Eastern Bankshares, Inc. | Rivers Robert Francis | Director, Officer - Chair and CEO | Savings Institution, Federally Chartered | BUY | $10.00 | 200,000 | $2,000,000 | 200,000 | +100.0% |
| 2020-10-17 00:00 | 2020-08-21 | HRMY | Harmony Biosciences Holdings, Inc. | Marshman Fund Trust II | 10% owner | Pharmaceutical Preparations | BUY | $24.00 | 339,476 | $8,147,424 | 10,651,120 | +3.3% |
| 2020-10-16 22:36 | 2020-10-14 | KRON | N/A | Bischofberger Norbert W. & Inger A. Revocable Inter Vivos Trust | 10% owner | Other | BUY | $19.00 | 95,500 | $1,814,500 | 4,370,496 | +2.2% |
| 2020-10-16 19:24 | 2020-10-14 | SPRB | SPRUCE BIOSCIENCES, INC. | Muralidhar Bali | Director | Pharmaceutical Preparations | BUY | $15.00 | 200,000 | $3,000,000 | 1,792,518 | +12.6% |
| 2020-10-16 19:21 | 2020-10-14 | SPRB | SPRUCE BIOSCIENCES, INC. | O'Donnell Niall | Director | Pharmaceutical Preparations | BUY | $15.00 | 250,000 | $3,750,000 | 695,905 | +56.1% |
| 2020-10-16 19:15 | 2020-10-14 | SPRB | SPRUCE BIOSCIENCES, INC. | Omega Fund VI, L.P. | Other | Pharmaceutical Preparations | BUY | $15.00 | 250,000 | $3,750,000 | 2,161,022 | +13.1% |
| 2020-10-16 19:14 | 2020-10-14 | SPRB | SPRUCE BIOSCIENCES, INC. | Chaya Moghrabi Dina | Director | Pharmaceutical Preparations | BUY | $15.00 | 250,000 | $3,750,000 | 2,161,022 | +13.1% |
| 2020-10-16 19:08 | 2020-10-14 | SPRB | SPRUCE BIOSCIENCES, INC. | HealthCap VIII, L.P. | Other | Pharmaceutical Preparations | BUY | $15.00 | 250,000 | $3,750,000 | 2,033,621 | +14.0% |
| 2020-10-16 19:07 | 2020-10-14 | SPRB | SPRUCE BIOSCIENCES, INC. | HANSSON JONAS | Director | Pharmaceutical Preparations | BUY | $15.00 | 250,000 | $3,750,000 | 2,033,621 | +14.0% |
| 2020-10-16 19:34 | 2020-10-14 | SPRB | SPRUCE BIOSCIENCES, INC. | RiverVest Venture Fund III, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $15.00 | 250,000 | $3,750,000 | 2,148,281 | +13.2% |
| 2020-10-17 04:30 | 2020-10-16 | ETON | Eton Pharmaceuticals, Inc. | Opaleye Management Inc. | 10% owner | Pharmaceutical Preparations | BUY | $7.00 | 400,000 | $2,800,000 | 155,000 | +100.0% |
| 2020-10-17 00:22 | 2020-10-14 | EBC | Eastern Bankshares, Inc. | Borgen Luis | Director | Savings Institution, Federally Chartered | BUY | $10.00 | 100,000 | $1,000,000 | 46,270 | +100.0% |
| 2020-10-16 23:49 | 2020-10-14 | SPRB | SPRUCE BIOSCIENCES, INC. | Novo Holdings A/S | 10% owner | Pharmaceutical Preparations | BUY | $15.00 | 250,000 | $3,750,000 | 4,989,336 | +5.3% |
| 2020-10-16 22:58 | 2020-10-14 | KRON | N/A | Omega Fund V, L.P. | 10% owner | Other | BUY | $19.00 | 450,000 | $8,550,000 | 3,818,283 | +13.4% |
| 2020-10-16 22:56 | 2020-10-14 | KRON | N/A | Stampacchia Otello | Director, 10% owner | Other | BUY | $19.00 | 450,000 | $8,550,000 | 3,818,283 | +13.4% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.